LeMaitre Vascular

Live  

LeMaitre Vascular is a global medical device company that specializes in developing and providing innovative devices and solutions for the treatment of peripheral vascular disease. The company was founded in 1983 and is headquartered in Burlington, Massachusetts.
Products and services
The company's products and services are focused on five main categories:
1. Open vascular surgery: This includes a range of surgical instruments and accessories for a variety of open surgical procedures, including aortic repair, peripheral bypass, and carotid endarterectomy.
2. Endovascular surgery: LeMaitre Vascular offers a range of endovascular devices, including stent grafts, balloon catheters, and vascular access products.
3. Compression therapy: The company provides a variety of products for venous and lymphatic disorders, including compression garments, pumps, and bandages.
4. Dialysis: LeMaitre Vascular offers a range of products for hemodialysis access, including catheters, grafts, and accessories.
5. Cardiac surgery: The company also offers a range of devices and solutions for cardiac surgery, including cannulae, tubing sets, and heart valve repair devices.
Global presence
LeMaitre Vascular has a presence in over 80 countries worldwide, with subsidiaries and distribution partners in Europe, Latin America, Asia-Pacific, and the Middle East. The company's products are sold in over 50 countries and are used by over 13,000 surgeons.
Research and development
The company is committed to investing in research and development to bring new and innovative products to the market. LeMaitre Vascular has a team of over 100 scientists, engineers, and product managers dedicated to developing new technologies and improving existing products.
Partnerships and collaborations
LeMaitre Vascular works closely with physicians and medical professionals to understand their needs and develop products that meet their specific requirements. The company also partners with other medical device companies and institutions to expand its product portfolio and offer comprehensive solutions for vascular disease treatment.
Financial information
LeMaitre Vascular is a publicly traded company on the Nasdaq stock exchange (Ticker Symbol: LMAT). As of 2021, the company's annual revenue was $144.74 million.

LeMaitre Vascular is a company that makes special medical devices and products for doctors and hospitals. These devices help people who have problems with their blood vessels, which are the tubes in our bodies that carry blood. Sometimes these blood vessels can get blocked or damaged, and that can make it hard for blood to flow properly.
LeMaitre Vascular creates tools like balloons that can help open up these blocked blood vessels, as well as stents, which are little supports that keep blood vessels open. They also make other products to fix or help with blood vessel issues, like surgical instruments and special protective covers.
The company makes money by selling these products to hospitals and doctors who use them to help their patients. When doctors perform surgeries or procedures to fix blood vessels, they need these tools to do it safely and effectively.
One reason LeMaitre Vascular is successful is that there will always be people who need medical help, especially with heart and blood vessel problems, which are quite common. They focus on creating high-quality products that doctors trust. If doctors trust and like their products, they will keep buying them.
Another reason the company will likely stay successful is because they are constantly working on new and better products. As technology improves, they study how to create better solutions for blood vessel problems, which keeps them ahead of other companies.
So, because LeMaitre Vascular makes important products that help people feel better and they’re always trying to improve what they offer, it seems they will keep doing well in the future!

MS4gV29ybG QtcmVub3du ZWQgcmVwdX RhdGlvbjog TGVNYWl0cm UgVmFzY3Vs YXIgaXMgYS BsZWFkaW5n IGdsb2JhbC Bwcm92aWRl ciBvZiBtZW RpY2FsIGRl dmljZXMgZm 9yIHRoZSB0 cmVhdG1lbn Qgb2YgcGVy aXBoZXJhbC B2YXNjdWxh ciBkaXNlYX NlLiBUaGUg Y29tcGFueS BoYXMgYSBs b25nLXN0YW 5kaW5nIHJl cHV0YXRpb2 4gZm9yIGhp Z2gtcXVhbG l0eSBwcm9k dWN0cyBhbm QgaW5ub3Zh dGlvbiBpbi B0aGUgbWVk aWNhbCBkZX ZpY2UgaW5k dXN0cnkuPG JyPjIuIEZv Y3VzIG9uIH Zhc2N1bGFy IHN1cmdlcn k6IExlTWFp dHJlIFZhc2 N1bGFyIGV4 Y2x1c2l2ZW x5IGZvY3Vz ZXMgb24gcH JvZHVjdHMg YW5kIHNvbH V0aW9ucyBm b3IgdmFzY3 VsYXIgc3Vy Z2VyeSwgbW FraW5nIHRo ZW0gZXhwZX J0cyBpbiB0 aGlzIGZpZW xkLjxicj4z LiBXaWRlIH JhbmdlIG9m IHByb2R1Y3 RzOiBUaGUg Y29tcGFueS BvZmZlcnMg YSBjb21wcm VoZW5zaXZl IHBvcnRmb2 xpbyBvZiBv dmVyIDUwMC B2YXNjdWxh ciBkZXZpY2 VzLCBpbmNs dWRpbmcgZG V2aWNlcyBm b3Igb3Blbi BhbmQgZW5k b3Zhc2N1bG FyIHByb2Nl ZHVyZXMsIG FzIHdlbGwg YXMgZm9yIH RoZSB0cmVh dG1lbnQgb2 YgdmVub3Vz IGRpc2Vhc2 UuPGJyPjQu IE9uZ29pbm cgcHJvZHVj dCBpbm5vdm F0aW9uOiBM ZU1haXRyZS BWYXNjdWxh ciBpbnZlc3 RzIGhlYXZp bHkgaW4gcm VzZWFyY2gg YW5kIGRldm Vsb3BtZW50 IHRvIGNvbn RpbnVvdXNs eSBpbXByb3 ZlIGFuZCBl eHBhbmQgdG hlaXIgcHJv ZHVjdCBvZm ZlcmluZ3Mu IFRoZXkgaG F2ZSBhIGRl ZGljYXRlZC B0ZWFtIG9m IGVuZ2luZW VycyBhbmQg c2NpZW50aX N0cyBmb2N1 c2VkIG9uIG RldmVsb3Bp bmcgbmV3IG FuZCBpbm5v dmF0aXZlIH NvbHV0aW9u cyBmb3Igdm FzY3VsYXIg c3VyZ2VyeS 48YnI+NS4g U3Ryb25nIH ByZXNlbmNl IGluIGdsb2 JhbCBtYXJr ZXRzOiBUaG UgY29tcGFu eSBoYXMgYS BzdHJvbmcg aW50ZXJuYX Rpb25hbCBw cmVzZW5jZS B3aXRoIG9w ZXJhdGlvbn MgaW4gRXVy b3BlLCBBc2 lhLCBhbmQg TGF0aW4gQW 1lcmljYSwg YWxsb3dpbm cgdGhlbSB0 byByZWFjaC BhIHdpZGUg cmFuZ2Ugb2 YgY3VzdG9t ZXJzIGdsb2 JhbGx5Ljxi cj42LiBDb2 1taXRtZW50 IHRvIHBhdG llbnQgc2Fm ZXR5OiBMZU 1haXRyZSBW YXNjdWxhci BpcyBjb21t aXR0ZWQgdG 8gcGF0aWVu dCBzYWZldH kgYW5kIGhh cyBhIHJpZ2 9yb3VzIHF1 YWxpdHkgbW FuYWdlbWVu dCBzeXN0ZW 0gaW4gcGxh Y2UgdG8gZW 5zdXJlIHRo ZWlyIHByb2 R1Y3RzIG1l ZXQgdGhlIG hpZ2hlc3Qg c3RhbmRhcm RzLjxicj43 LiBFbXBoYX NpcyBvbiBl ZHVjYXRpb2 4gYW5kIHRy YWluaW5nOi BUaGUgY29t cGFueSBoYX MgYSBzdHJv bmcgZW1waG FzaXMgb24g ZWR1Y2F0aW 9uIGFuZCB0 cmFpbmluZy wgb2ZmZXJp bmcgcHJvZ3 JhbXMgYW5k IHJlc291cm NlcyB0byBo ZWxwIGhlYW x0aGNhcmUg cHJvZmVzc2 lvbmFscyBz dGF5IHVwLX RvLWRhdGUg b24gdGhlIG xhdGVzdCB0 ZWNobmlxdW VzIGFuZCB0 ZWNobm9sb2 dpZXMgaW4g dmFzY3VsYX Igc3VyZ2Vy eS48YnI+OC 4gU3Ryb25n IHBhcnRuZX JzaGlwcyBh bmQgY29sbG Fib3JhdGlv bnM6IExlTW FpdHJlIFZh c2N1bGFyIH dvcmtzIGNs b3NlbHkgd2 l0aCBsZWFk aW5nIHZhc2 N1bGFyIHN1 cmdlb25zIG FuZCBoZWFs dGhjYXJlIG 9yZ2FuaXph dGlvbnMgdG 8gZGV2ZWxv cCBhbmQgcm VmaW5lIHRo ZWlyIHByb2 R1Y3RzLCBl bnN1cmluZy B0aGF0IHRo ZXkgbWVldC B0aGUgbmVl ZHMgb2YgcG F0aWVudHMg YW5kIHBoeX NpY2lhbnMu PGJyPjkuIE NvcnBvcmF0 ZSBzb2NpYW wgcmVzcG9u c2liaWxpdH k6IFRoZSBj b21wYW55IG hhcyBhIHN0 cm9uZyBjb2 1taXRtZW50 IHRvIGNvcn BvcmF0ZSBz b2NpYWwgcm VzcG9uc2li aWxpdHksIG ZvY3VzaW5n IG9uIHN1c3 RhaW5hYmls aXR5LCBldG hpY2FsIGJ1 c2luZXNzIH ByYWN0aWNl cywgYW5kIG dpdmluZyBi YWNrIHRvIH RoZSBjb21t dW5pdGllcy BpbiB3aGlj aCB0aGV5IG 9wZXJhdGUu PGJyPjEwLi BBd2FyZHMg YW5kIHJlY2 9nbml0aW9u OiBMZU1haX RyZSBWYXNj dWxhciBoYX MgcmVjZWl2 ZWQgbnVtZX JvdXMgYXdh cmRzIGFuZC ByZWNvZ25p dGlvbiBmb3 IgdGhlaXIg cHJvZHVjdH MsIGlubm92 YXRpb24sIG FuZCBidXNp bmVzcyBwcm FjdGljZXMs IGluY2x1ZG luZyBiZWlu ZyBuYW1lZC BvbmUgb2Yg Rm9yYmVzJy BCZXN0IFNt YWxsIENvbX BhbmllcyBp biBBbWVyaW NhLg==

TGVNYWl0cm UgVmFzY3Vs YXIgaXMgYS BtZWRpY2Fs IGRldmljZS Bjb21wYW55 IHRoYXQgc3 BlY2lhbGl6 ZXMgaW4gdG hlIGRldmVs b3BtZW50LC BtYW51ZmFj dHVyaW5nLC BhbmQgbWFy a2V0aW5nIG 9mIGlubm92 YXRpdmUgdm FzY3VsYXIg YW5kIGVuZG 92YXNjdWxh ciBwcm9kdW N0cyBmb3Ig dGhlIHRyZW F0bWVudCBv ZiBwZXJpcG hlcmFsIHZh c2N1bGFyIG Rpc2Vhc2Uu IFRoZWlyIG J1c2luZXNz IG1vZGVsIG ZvY3VzZXMg b24gZm91ci BrZXkgYXJl YXM6IHJlc2 VhcmNoIGFu ZCBkZXZlbG 9wbWVudCwg cHJvZHVjdG lvbiBhbmQg ZGlzdHJpYn V0aW9uLCBz YWxlcyBhbm QgbWFya2V0 aW5nLCBhbm QgY3VzdG9t ZXIgc2Vydm ljZS48YnI+ MS4gUmVzZW FyY2ggYW5k IERldmVsb3 BtZW50OiBM ZU1haXRyZS BWYXNjdWxh ciBpbnZlc3 RzIGhlYXZp bHkgaW4gcm VzZWFyY2gg YW5kIGRldm Vsb3BtZW50 IHRvIGNvbn RpbnVvdXNs eSBpbXByb3 ZlIHRoZWly IGV4aXN0aW 5nIHByb2R1 Y3RzIGFuZC BkZXZlbG9w IG5ldywgY3 V0dGluZy1l ZGdlIHRlY2 hub2xvZ2ll cy4gVGhlIG NvbXBhbnkg aGFzIGEgdG VhbSBvZiBz Y2llbnRpc3 RzLCBlbmdp bmVlcnMsIG FuZCBjbGlu aWNpYW5zIH dobyB3b3Jr IHRvZ2V0aG VyIHRvIGRl c2lnbiBhbm QgZGV2ZWxv cCBpbm5vdm F0aXZlIHNv bHV0aW9ucy Bmb3IgdmFz Y3VsYXIgc3 VyZ2VvbnMg YW5kIGludG VydmVudGlv bmFsaXN0cy 48YnI+Mi4g UHJvZHVjdG lvbiBhbmQg RGlzdHJpYn V0aW9uOiBM ZU1haXRyZS BWYXNjdWxh ciBtYW51Zm FjdHVyZXMg aXRzIHByb2 R1Y3RzIGlu LWhvdXNlLC BlbnN1cmlu ZyBzdHJpY3 QgcXVhbGl0 eSBjb250cm 9sIGFuZCB0 aW1lbHkgZG VsaXZlcnku IFRoZSBjb2 1wYW55IG9w ZXJhdGVzIG Rpc3RyaWJ1 dGlvbiBjZW 50ZXJzIGlu IHRoZSBVbm l0ZWQgU3Rh dGVzLCBFdX JvcGUsIGFu ZCBBc2lhIH RvIGVmZmlj aWVudGx5IH N1cHBseSBp dHMgcHJvZH VjdHMgdG8g aGVhbHRoY2 FyZSBwcm92 aWRlcnMgd2 9ybGR3aWRl Ljxicj4zLi BTYWxlcyBh bmQgTWFya2 V0aW5nOiBM ZU1haXRyZS BWYXNjdWxh ciBoYXMgYS BkaXJlY3Qg c2FsZXMgZm 9yY2UgdGhh dCBtYXJrZX RzIGl0cyBw cm9kdWN0cy B0byBob3Nw aXRhbHMsIG FtYnVsYXRv cnkgc3VyZ2 VyeSBjZW50 ZXJzLCBhbm QgaGVhbHRo Y2FyZSBmYW NpbGl0aWVz IGJvdGggZG 9tZXN0aWNh bGx5IGFuZC BpbnRlcm5h dGlvbmFsbH kuIFRoZSBj b21wYW55IG Fsc28gcGFy dG5lcnMgd2 l0aCBrZXkg ZGlzdHJpYn V0b3JzIGFu ZCBvdGhlci B0aGlyZC1w YXJ0eSBzYW xlcyBvcmdh bml6YXRpb2 5zIHRvIGV4 cGFuZCBpdH MgcmVhY2gu PGJyPjQuIE N1c3RvbWVy IFNlcnZpY2 U6IExlTWFp dHJlIFZhc2 N1bGFyIGlz IGNvbW1pdH RlZCB0byBw cm92aWRpbm cgZXhjZWxs ZW50IGN1c3 RvbWVyIHNl cnZpY2UsIG luY2x1ZGlu ZyBjbGluaW NhbCB0cmFp bmluZywgdG VjaG5pY2Fs IHN1cHBvcn QsIGFuZCBv bi1zaXRlIG Fzc2lzdGFu Y2UuIFRoZS Bjb21wYW55 IGFsc28gb2 ZmZXJzIGEg Y29tcHJlaG Vuc2l2ZSB3 YXJyYW50eS BhbmQgcmVw YWlyIHByb2 dyYW0gdG8g ZW5zdXJlIG N1c3RvbWVy IHNhdGlzZm FjdGlvbiBh bmQgbWluaW 1pemUgZG93 bnRpbWUuPG JyPk92ZXJh bGwsIExlTW FpdHJlIFZh c2N1bGFyJ3 MgYnVzaW5l c3MgbW9kZW wgZm9jdXNl cyBvbiBwcm 92aWRpbmcg aGlnaC1xdW FsaXR5LCBp bm5vdmF0aX ZlIHByb2R1 Y3RzIGFuZC Bjb21wcmVo ZW5zaXZlIH N1cHBvcnQg c2VydmljZX MgdG8gaGVh bHRoY2FyZS Bwcm92aWRl cnMsIGluIG 9yZGVyIHRv IGltcHJvdm UgcGF0aWVu dCBvdXRjb2 1lcyBhbmQg YmVjb21lIG EgdHJ1c3Rl ZCBwYXJ0bm VyIGluIHRo ZSB0cmVhdG 1lbnQgb2Yg cGVyaXBoZX JhbCB2YXNj dWxhciBkaX NlYXNlLg==

AI can pose potential threats to a company like LeMaitre Vascular, which specializes in medical devices and vascular surgery products, through several avenues.
1. Substitution: AI technologies may lead to the development of alternative treatment methods or medical devices that can outperform existing products. For example, AI-driven surgical robots or minimally invasive techniques could provide better patient outcomes, leading to a shift away from traditional vascular surgical products. If competitors leverage AI to innovate faster or create superior solutions, it could threaten LeMaitre’s market share.
2. Disintermediation: AI can facilitate direct connections between healthcare providers and patients, potentially displacing established companies that act as intermediaries. For example, telemedicine and AI-driven diagnostics may reduce reliance on traditional products or services offered by companies like LeMaitre, as healthcare providers adopt new technologies that streamline processes and improve efficiency.
3. Margin Pressure: The integration of AI can lead to cost reductions for competitors, allowing them to offer lower prices for similar products. If LeMaitre cannot match these prices without compromising its value proposition, it could face increased margin pressure. Additionally, if AI systems enhance operational efficiencies, competitors might be able to operate at lower costs, further intensifying price competition in the market.
Overall, while AI presents opportunities for innovation and improvement, it also poses risks that LeMaitre Vascular must actively monitor to safeguard its competitive positioning and ensure its products and services continue to meet market demands.

The sensitivity of LeMaitre Vascular’s earnings, cash flow, and valuation to changes in interest rates can be analyzed across several dimensions:
1. Earnings Impact: Higher interest rates can lead to increased borrowing costs for companies, potentially impacting LeMaitre Vascular if they rely on debt for financing operations, expansion, or R&D. Additionally, if interest rates rise, consumer spending may decrease, which can affect sales of their medical devices, especially in elective surgeries where patients might delay procedures due to costs.
2. Cash Flow Considerations: Cash flow sensitivity to interest rates primarily arises from changes in the cost of servicing debt. If LeMaitre has variable-rate debt, rising interest rates could increase interest payments, reducing net cash flow. Conversely, stable or declining interest rates could benefit the company’s cash flow by reducing debt service burdens.
3. Valuation Effects: Interest rates are a key component in discounting future cash flows during valuation. Higher interest rates typically lead to lower present values for future earnings, which can reduce the overall valuation of the company. Investors often require a higher return in a higher interest rate environment, which could further compress LeMaitre’s valuation multiples.
4. Market Competitiveness: In a rising interest rate environment, companies with lower debt levels and stronger balance sheets may have a competitive advantage. If LeMaitre Vascular manages its capital efficiently, it may be better positioned to withstand the pressures that accompany rising rates, such as increased competition from similarly situated firms facing higher capital costs.
5. Investment in Growth: Interest rate changes can affect LeMaitre’s decisions around capital expenditures and investment in new technologies or product lines. Higher rates might deter investment due to the increased cost of financing, potentially impacting long-term growth prospects.
In summary, LeMaitre Vascular’s sensitivity to interest rate changes is multifaceted, impacting its earnings through financing costs and consumer spending patterns, influencing cash flow primarily through debt servicing, and affecting valuation subjects to adjustment in discount rates applied by investors. Careful management of debt levels and capital allocation can help mitigate these sensitivities.

CiAgICAgIC AgICAgIDxk aXYgc3R5bG U9J3dpZHRo OiAxMDAlOy BkaXNwbGF5 OiBmbGV4Oy BqdXN0aWZ5 LWNvbnRlbn Q6IGNlbnRl cjsnPgogIC AgICAgICAg ICAgICAgPG RpdiBzdHls ZT0nCiAgIC AgICAgICAg ICAgICAgIC AgZGlzcGxh eTogZmxleD sKICAgICAg ICAgICAgIC AgICAgICBh bGlnbi1pdG VtczogY2Vu dGVyOwogIC AgICAgICAg ICAgICAgIC AgIGJhY2tn cm91bmQtY2 9sb3I6ICNm MGY0Zjg7Ci AgICAgICAg ICAgICAgIC AgICAgYm9y ZGVyOiAxcH ggc29saWQg I2QxZTNmMD sKICAgICAg ICAgICAgIC AgICAgICBi b3JkZXItcm FkaXVzOiAx MHB4OwogIC AgICAgICAg ICAgICAgIC AgIHBhZGRp bmc6IDEwcH g7CiAgICAg ICAgICAgIC AgICAgICAg bWFyZ2luOi AyMHB4IDA7 CiAgICAgIC AgICAgICAg ICAgICAgZm 9udC1mYW1p bHk6ICJTZW dvZSBVSSIs IFJvYm90by wgc2Fucy1z ZXJpZjsKIC AgICAgICAg ICAgICAgIC AgICBib3gt c2hhZG93Oi AwIDJweCA2 cHggcmdiYS gwLCAwLCAw LCAwLjA1KT sKICAgICAg ICAgICAgIC AgICAgICBt YXgtd2lkdG g6IDkwMHB4 OwogICAgIC AgICAgICAg ICAgICAgIH dpZHRoOiAx MDAlOyc+Cg ogICAgICAg ICAgICAgIC AgICAgIDxp bWcgc3JjPS Jhc3NldHMv bG9nb3MvU1 l4dTMwTjM2 dTQ5WEFNd0 4xRlEud2Vi cCIgYWx0PS JMZU1haXRy ZSBWYXNjdW xhciIgdGl0 bGU9IkxlTW FpdHJlIFZh c2N1bGFyIi AgY2xhc3M9 ImltZy1mbH VpZCIgaGVp Z2h0PTkwIH dpZHRoPTkw IGxvYWRpbm c9J2xhenkn IHN0eWxlPS dib3JkZXIt cmFkaXVzOi A2cHg7Jz4K CiAgICAgIC AgICAgICAg ICAgICAgPG RpdiBzdHls ZT0nZmxleD ogMTsgdGV4 dC1hbGlnbj ogY2VudGVy OyBtYXJnaW 4tbGVmdDog NXB4Oyc+Ci AgICAgICAg ICAgICAgIC AgICAgICAg IDxwIHN0eW xlPSdmb250 LXNpemU6ID I2cHg7IGNv bG9yOiAjMz MzOyBtYXJn aW4tYm90dG 9tOiAxNXB4 Oyc+CiAgIC AgICAgICAg ICAgICAgIC AgICAgICAg ICDwn5OIIF dhbnQgdG8g cmVhZCBtb3 JlIGFib3V0 IExlTWFpdH JlIFZhc2N1 bGFyPwogIC AgICAgICAg ICAgICAgIC AgICAgICA8 L3A+CgogIC AgICAgICAg ICAgICAgIC AgICAgICA8 YSBocmVmPS dpbmRleC5w aHA/cGFnZT 1zaWdudXAn IHN0eWxlPS cKICAgICAg ICAgICAgIC AgICAgICAg ICAgICAgIG JhY2tncm91 bmQtY29sb3 I6ICMwMDdC RkY7CiAgIC AgICAgICAg ICAgICAgIC AgICAgICAg ICBjb2xvcj ogI2ZmZjsK ICAgICAgIC AgICAgICAg ICAgICAgIC AgICAgIHBh ZGRpbmc6ID EwcHggMjBw eDsKICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg IGJvcmRlci 1yYWRpdXM6 IDVweDsKIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAgIHRleH QtZGVjb3Jh dGlvbjogbm 9uZTsKICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgIGZvbnQt d2VpZ2h0Oi Bib2xkOwog ICAgICAgIC AgICAgICAg ICAgICAgIC AgICAgbWFy Z2luLXJpZ2 h0OiAxMHB4 OwogICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg dHJhbnNpdG lvbjogYmFj a2dyb3VuZC 1jb2xvciAw LjNzIGVhc2 U7JwogICAg ICAgICAgIC AgICAgICAg ICAgICAgIC Agb25tb3Vz ZW92ZXI9J3 RoaXMuc3R5 bGUuYmFja2 dyb3VuZENv bG9yPSIjMD A1NmIzIicK ICAgICAgIC AgICAgICAg ICAgICAgIC AgICAgIG9u bW91c2VvdX Q9J3RoaXMu c3R5bGUuYm Fja2dyb3Vu ZENvbG9yPS IjMDA3QkZG Iic+CiAgIC AgICAgICAg ICAgICAgIC AgICAgICAg ICBTaWduIH VwIGZvciBm cmVlCiAgIC AgICAgICAg ICAgICAgIC AgICAgIDwv YT4KCiAgIC AgICAgICAg ICAgICAgIC AgICAgIDxz cGFuIHN0eW xlPSdtYXJn aW46IDAgOH B4OyBjb2xv cjogIzU1NT snPm9yPC9z cGFuPgoKIC AgICAgICAg ICAgICAgIC AgICAgICAg PGEgaHJlZj 0naW5kZXgu cGhwP3BhZ2 U9bG9naW4n IHN0eWxlPS cKICAgICAg ICAgICAgIC AgICAgICAg ICAgICAgIG NvbG9yOiAj MDA3QkZGOw ogICAgICAg ICAgICAgIC AgICAgICAg ICAgICAgdG V4dC1kZWNv cmF0aW9uOi B1bmRlcmxp bmU7CiAgIC AgICAgICAg ICAgICAgIC AgICAgICAg ICBmb250LX dlaWdodDog NTAwOyc+Ci AgICAgICAg ICAgICAgIC AgICAgICAg ICAgICBsb2 cgaW4KICAg ICAgICAgIC AgICAgICAg ICAgICAgPC 9hPgoKCiAg ICAgICAgIC AgICAgICAg ICAgICAgID xwIHN0eWxl PSdtYXJnaW 4tdG9wOiAx NXB4OyBmb2 50LXNpemU6 IDEzcHg7IG ZvbnQtd2Vp Z2h0OiBib2 xkOyBjb2xv cjogI2QzMm YyZjsnPgog ICAgICAgIC AgICAgICAg ICAgICAgIC AgICAg8J+S oSBMZWFybi BzbWFydGVy IHN0b2NrIH BpY2tzIHdp dGggPGk+Il RoZSBDaGVj a2xpc3QgVm FsdWUgSW52 ZXN0b3Ig4o CUIEEgU21h cnRlciBXYX kgdG8gUGlj ayBTdG9ja3 MiPC9pPgog ICAgICAgIC AgICAgICAg ICAgICAgIC A8L3A+Cgog ICAgICAgIC AgICAgICAg ICAgICAgIC A8IS0tCiAg ICAgICAgIC AgICAgICAg ICAgICAgID xkaXYgc3R5 bGU9J21hcm dpbi10b3A6 IDEycHg7IG ZvbnQtc2l6 ZTogMTNweD sgY29sb3I6 ICM0NDQ7Jz 4KICAgICAg ICAgICAgIC AgICAgICAg ICAgICAgIF NpZ24gdXAg bm93IGFuZC BnZXQgb3Vy IGZyZWUgZU Jvb2sgCiAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgICA8Yj5U aGUgQ2hlY2 tsaXN0IFZh bHVlIEludm VzdG9yIOKA lCBBIFNtYX J0ZXIgV2F5 IHRvIFBpY2 sgU3RvY2tz PC9iPgogIC AgICAgICAg ICAgICAgIC AgICAgICA8 L2Rpdj4KIC AgICAgICAg ICAgICAgIC AgICAgICAg LS0+CiAgIC AgICAgICAg ICAgICAgIC AgICAgIDwh LS0KICAgIC AgICAgICAg ICAgICAgIC AgICAgPGRp diBzdHlsZT 0nbWFyZ2lu LXRvcDogMT ZweDsgZm9u dC1zaXplOi AxNHB4OyBj b2xvcjogIz Q0NDsgZm9u dC1mYW1pbH k6IC1hcHBs ZS1zeXN0ZW 0sIEJsaW5r TWFjU3lzdG VtRm9udCwg U2Vnb2UgVU ksIFJvYm90 bywgSGVsdm V0aWNhIE5l dWUsIHNhbn Mtc2VyaWY7 IGxpbmUtaG VpZ2h0OiAx LjY7Jz4KIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAgIEhhdm UgeW91IGhl YXJkIGFib3 V0IG91ciBz aG9ydCA8c3 Ryb25nIHN0 eWxlPSdmb2 50LXdlaWdo dDogNjAwOy c+RGFpbHkg VmlkZW8gTm V3c2xldHRl cjwvc3Ryb2 5nPj8KICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgIDxhIGhy ZWY9J2h0dH BzOi8vd3d3 Lmluc2lnaH RmdWx2YWx1 ZS5jb20vbm V3c2xldHRl ci5waHAnIH RhcmdldD0n X2JsYW5rJy BzdHlsZT0n Y29sb3I6IC MwMDdCRkY7 IHRleHQtZG Vjb3JhdGlv bjogbm9uZT sgZm9udC13 ZWlnaHQ6ID UwMDsgbWFy Z2luLWxlZn Q6IDZweDsn PgogICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAgIEZpbm Qgb3V0IG1v cmUKICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg IDwvYT4KIC AgICAgICAg ICAgICAgIC AgICAgICAg PC9kaXY+Ci AgICAgICAg ICAgICAgIC AgICAgICAg IC0tPgogIC AgICAgICAg ICAgICAgIC AgIDwvZGl2 PgogICAgIC AgICAgICAg ICAgPC9kaX Y+CiAgICAg ICAgICAgID wvZGl2Pgog ICAgICAgIC AgICAKICAg ICAgICAKIC AgICAgICA8 c3BhbiBjbG Fzcz0nYmx1 cnJlZC10ZX h0Jz4KICAg ICAgICAgIC AgTVNrZ1ZH aGxJRSB4bF RXRnBkSEps IElGWmhjMk 4xYkcgRnlJ R052YlhCaC BibmtnZDJG eklHIFp2ZF c1a1pXUWcg YVc0Z01Uaz RNeSBCaWVT QkhaVzl5IF oyVWdUR1ZO WVcgbDBjbV VzSUdFZyBk bUZ6WTNWc1 lYIElnYzNW eVoyVnYgYm k0Z1BHSnlQ aiBJcElGUm 9aU0JqIGIy MXdZVzU1SU ggTndaV05w WVd4cCBlbV Z6SUdsdUlH IFJsZG1Wc2 IzQnAgYm1j Z1lXNWtJRy AxaGNtdGxk R2x1IFp5Qn RaV1JwWTIg RnNJR1JsZG 1saiBaWE1n Wm05eUlIIF JvWlNCMGNt VmggZEcxbG JuUWdiMiBZ Z2NHVnlhWE JvIFpYSmhi Q0IyWVggTm pkV3hoY2lC ayBhWE5sWV hObExDIEIz YUdsamFDQm ggWm1abFkz UnpJSCBSb1 pTQmliRzl2 IFpDQjJaWE 56WlcgeHpJ RzkxZEhOcC BaR1VnYjJZ Z2RHIGhsSU dobFlYSjAg SUdGdVpDQm ljbSBGcGJp NGdQR0p5IF BqTXBJRWww Y3kgQm9aV0 ZrY1hWaCBj blJsY25NZ1 lYIEpsSUd4 dlkyRjAgWl dRZ2FXNGdR biBWeWJHbH VaM1J2IGJp d2dUV0Z6Yz IgRmphSFZ6 WlhSMCBjeX dnWVc1a0lH IGwwSUdoaG N5QmggSUdk c2IySmhiQy BCd2NtVnpa VzVqIFpTQj NhWFJvSUcg OXdaWEpoZE dsdiBibk1n YVc0Z1JYIF Z5YjNCbExD QkIgYzJsaE xDQmhibSBR Z1RHRjBhVz RnIFFXMWxj bWxqWVMgNG dQR0p5UGpR cCBJRXhsVF dGcGRIIEps SUZaaGMyTj EgYkdGeUlI ZGhjeSBCMG FHVWdabWx5 IGMzUWdZMj l0Y0cgRnVl U0IwYnlCdC BZWEpyWlhR Z2RHIGhsSU hWeVpYUmwg Y21Gc0lHTm hkRyBobGRH VnlMQ0IxIG MyVmtJSFJ2 SUggSmxiVz kyWlNCciBh V1J1WlhrZ2 MzIFJ2Ym1W eklIUm8gY2 05MVoyZ2dZ UyBCd1lYUn BaVzUwIDRv Q1pjeUIxY2 0gbHVZWEo1 SUhSeSBZV0 4wTGlBOFlu IEkrTlNrZ1 NYUWcgZDJG eklHRnNjMi A4Z2IyNWxJ RzltIElIUm 9aU0JtYVgg SnpkQ0JqYj IxdyBZVzVw WlhNZ2RHID hnYVc1MGNt OWsgZFdObE lIUm9aUyBC amIyNWpaWE IwIElHOW1J R1Z1WkcgOT JZWE5qZFd4 aCBjaUJ6ZF hKblpYIEo1 TENCM2FHbG ogYUNCMWRH bHNhWCBwbG N5QnRhVzVw IGJXRnNiSG tnYVcgNTJZ WE5wZG1VZy BkR1ZqYUc1 cGNYIFZsY3 lCMGJ5QjAg Y21WaGRDQj JZWCBOamRX eGhjaUJrIG FYTmxZWE5s Y3kgNGdQR0 p5UGpZcCBJ RWx1SURJd0 1UIEFzSUV4 bFRXRnAgZE hKbElGWmhj MiBOMWJHRn lJR0ZqIGNY VnBjbVZrSU ggUm9aU0J6 ZFhKbiBhV0 5oYkNCcGJu IE4wY25WdF pXNTAgY3lC a2FYWnBjMi BsdmJpQnZa aUJCIGJtZH BiM1JsWTIg Z2dVR2hoY2 0xaCBZMlYx ZEdsallXIH h6TENCSmJt TXUgTENCbG VIQmhibSBS cGJtY2dhWF J6IElIQnli MlIxWTMgUW djRzl5ZEda diBiR2x2TG lBOFluIEkr TnlrZ1ZHaG wgSUdOdmJY QmhibiBrZ2 FHRnpJSEps IFkyVnBkbV ZrSUcgNTFi V1Z5YjNWei BJR0YzWVhK a2N5IEJoYm 1RZ2NtVmog YjJkdWFYUn BiMiA0Z1pt OXlJR2wwIG N5QnBibTV2 ZG0gRjBhWF psSUcxbCBa R2xqWVd3Z1 pHIFYyYVdO bGN5d2cgYV c1amJIVmth VyA1bklIUm 9aU0JHIGNt OXpkQ0FtSU YgTjFiR3hw ZG1GdSBJRW R5YjNkMGFD IEJGZUdObG JHeGwgYm1O bElFeGxZVy BSbGNuTm9h WEFnIFFYZG hjbVFnYVcg NGdNakF4T1 M0ZyBQR0p5 UGpncElGIF JvWlNCdVlX MWwgSUV4bF RXRnBkSCBK bElHbHpJR1 JsIGNtbDJa V1FnWm4gSn ZiU0IwYUdV ZyBSbkpsYm 1Ob0lIIFJs Y20wZ2JHVW cgYldIRHJu UnlaUyB3Z2 QyaHBZMmdn IGJXVmhibk 1nZEcgaGxJ RzFoYzNSbC BjaUJ2Y2lC MGFHIFVnZE dWaFkyaGwg Y2k0Z1ZHaH BjeSBCeVpX WnNaV04wIG N5QjBhR1Vn WTIgOXRjR0 Z1ZWVLQSBt WE1nWTI5dG JXIGwwYldW dWRDQjAgYn lCamIyNXpk RyBGdWRHeD VJR3hsIFlY SnVhVzVuSU cgRnVaQ0Jw YlhCeSBiM1 pwYm1jZ2FX IDRnZEdobE lHWnAgWld4 a0lHOW1JSC BaaGMyTjFi R0Z5IElITj FjbWRsY24g a3VJRHhpY2 o0NSBLU0JN WlUxaGFYIF J5WlNCV1lY TmogZFd4aG NpQm9ZWCBN Z1lTQnpkSE p2IGJtY2da bTlqZFggTW diMjRnYzI5 aiBhV0ZzSU hKbGMzIEJ2 Ym5OcFltbH MgYVhSNUlH RnVaQyBCam IyNTBjbWxp IGRYUmxjeU IwYnkgQjJZ WEpwYjNWei BJR05vWVhK cGRHIEZpYk dVZ1kyRjEg YzJWekxDQn BibSBOc2RX UnBibWNnIG MzVndjRzl5 ZEcgbHVaeU JqYUdscyBa SEpsYnVLQW 1YIE1nYUdW aGJIUm8gWT JGeVpTQmhi bSBRZ2NISn ZkbWxrIGFX NW5JRzFsWk cgbGpZV3dn YzNWdyBjR3 hwWlhNZ2RH IDhnZFc1a1 pYSnogWlhK MlpXUWdjbS BWbmFXOXVj eTRnIFBHSn lQakV3S1Mg QkJjeUJ2Wm lBeSBNREl4 TENCMGFHIF VnWTI5dGNH RnUgZVNCb1 lYTWdiMyBa bGNpQXpOU0 J3IFlYUmxi blJ6SUcgRn VaQ0JqYjI1 MCBhVzUxWl hNZ2RHIDhn YVc1MlpYTj AgSUdsdUlI SmxjMiBWaG NtTm9JR0Z1 IFpDQmtaWF psYkcgOXdi V1Z1ZENCMC BieUJpY21s dVp5IEJwYm 01dmRtRjAg YVhabElITn ZiSCBWMGFX OXVjeUIwIG J5QjBhR1Vn YlcgRnlhMl YwSUdadiBj aUIwYUdVZ2 RIIEpsWVhS dFpXNTAgSU c5bUlIWmhj MiBOMWJHRn lJR1JwIGMy VmhjMlZ6TG cgPT0KICAg ICAgICA8L3 NwYW4+CiAg ICAgICAgCi AgICAgICAg